Home

International Advocacy

BIO and BVGH on Global Health

BIO's President and CEO Jim Greenwood talks to BIO Ventures for Global Health (BVGH) CEO Don Joseph about global health and BVGH's new report on global health.

BIO Media Briefing Highlights 2012 Policy Priorities

BIO President & CEO Jim Greenwood and Tom Watkins, President & CEO of Human Genome Sciences and Chair of BIO’s Board of Directors, recently hosted a media briefing to recap our advocacy accomplishments in 2011 and lay out BIO’s policy priorities for 2012.

The Future of Biotechnology in Japan

What does the future hold for the biotechnology industry in Japan? The Japanese government has made great strides to boost biotech within its borders.

60 Pavilions Showcase Countries, Regions and States at the 2012 BIO International Convention

Pavilions attract attendees and media alike, affording a space to tell your story within the context of a particular geographic region or specific focus area.

China: The Intersection of Innovation

In this informative editorial Jim Greenwood, BIO President and CEO, presents an insight into China’s growing role in the future of biotechnology.

BIO China Brings Together East and West for Partnering and Deal Making

This week’s BIO China International Conference displayed a growing recognition of China’s emergence as a global leader in the biotech industry and discussions focused on how to navigate the opportunities and challenges that exist in the rapidly emerging market.

BIO India Shines the Global Spotlight on Biotech in India

The buzz at BIO India hones in on the lack of clarity and consistency within the clinical trials process

BIO Returns to India and the Industry Continues to Grow

During this period of tremendous growth in both the Indian economy and its healthcare sector, it is a critical time to capitalize on the biotech opportunities available within India.

BIO China: Eastern Biotech Meets Western Biotech

With more than one-fifth of the world’s population, China is an important market for biotech products and is increasingly a key global player in biotech research, development and manufacturing.

Melinda Moree, CEO of BIO Ventures for Global Health

Moree discusses the Forum and the importance of partnering to improving the health of people in developing countries.

Bill Gates: Innovation is Key to Helping Poor Farmers

“I’ve never been a farmer,” Bill Gates confessed at The Chicago Council’s Symposium on Global Agriculture and Food Security. “Until recently, I rarely set foot on a farm.”

BIO Announces Dr. Jörg Reinhardt as Keynote Speaker for BIO China International Conference

WASHINGTON, D.C. (Tuesday, April 19, 2011) - The Biotechnology Industry Organization (BIO) announced today that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote address at the BIO China International Conference to be held October 12-13 in Shanghai, China. The event will bring together biotechnology and pharmaceutical leaders to explore business opportunities with life science companies in China.

Worldview: A Global Biotechnology Perspective

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

The Role of Intellectual Property in Global Health

BIO is committed to increased access to biologic medicines for patients throughout the world. 

The Future of Food Needs to Include Biotech Crops

You might have heard that the Prince of Wales, just days after hosting the Royal Wedding, paid us a visit here in Washington.  Prince Charles, a long-time organic food advocate and self-described environmentalist, was here to speak at a Washington Post symposium on the Future of Food.

Letters, Testimony & Comments

2012 Special 301 Report: Biotech's International IP Issues
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
China Compulsory License Proposed Provisions Draw Reaction from BIO
December 9 2011
By Electronic Submission To the State Intellectual Property Office, The Biotechnology Industry Organization (BIO) appreciates this...
International IP and Small Businesses: Novavax CEO Testifies on BIO's Behalf
October 27 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
BIO Submits "Guideline on similar biological medicinal products containing monoclonal antibodies" Comments to the European Medicines Agency (EMA)
May 31 2011
The Biotechnology Industry Organization (BIO) thanks the European Medicines Agency (EMA) for the opportunity to submit comments on the...
Australian Gene Patent Bill: BIO Comments to the Australian Senate Committee on Proposed Patent Amendment
February 25 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010 Submission to the Senate Legal and Constitutional Affairs Legislation...
More Letters, Testimony & Comments →

Press Releases

Orphan Diseases and the Future of BioPharma, the Focus of the 2012 Orphan Disease Forum
April 5 2012
WASHINGTON, D.C.(April 5, 2012)— Thought leaders from dozens of biotech and pharmaceutical corporations from...
BIO Encourages Swift Enactment of Korea-U.S. Free Trade Agreement
October 5 2011
Washington, D.C. (October 5, 2011) – The Biotechnology Industry Organization (BIO) welcomed the transmission of...
Civilian and Military Aviation Biofuels: Companies to Highlight New Technologies and Markets at BIO’s World Congress on Industrial Biotechnology
April 28 2011
WASHINGTON, D.C. (Thursday, April 28, 2011) - Biofuel research and development companies will present progress in...
Business Executives to Highlight Opportunities for New Product Development from Renewables at BIO’s World Congress
April 21 2011
WASHINGTON, D.C. (Thursday, April 21, 2011) - Corporate leaders will discuss benefits for businesses and consumers...
BIO Announces Dr. Jörg Reinhardt as Keynote Speaker for BIO China International Conference
April 19 2011
WASHINGTON, D.C. (Tuesday, April 19, 2011) - The Biotechnology Industry Organization (BIO) announced today that Dr. J...
More Press Releases →